Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05595837 · ClinicalTrials.gov registry record
Immune Registry for Organ Transplantation From COVID Positive Donors.
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 20
- Enrollment target
NCT05595837 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 20 participants.
The verdict
NCT05595837 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data generated by standard clinical practice to determine the short term and long term clinical outcomes of recipients of solid organ transplantation from COVID-19 infected donors and compare it to recipients with organ transplant from COVID-19 negative donors.
Interventions
- OTHER Standard organ transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-12-29 |
| Est. Completion | 2025-07-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05595837
The ClinicalTrials.gov registry entry for NCT05595837 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard organ transplant is the first listed.
NCT05595837 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05595837 about?
NCT05595837 is a clinical study titled "Immune Registry for Organ Transplantation From COVID Positive Donors.". The purpose of this study is to collect data generated by standard clinical practice to determine the short term and long term clinical outcomes of recipients of solid organ transplantation from COVID-19 infected donors and compare it to recipients with organ transplant from COVID-19 negative donors...
What is the current status of trial NCT05595837?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-12-29. Estimated completion is 2025-07-20.
What interventions are being tested in trial NCT05595837?
The interventions under investigation include: Standard organ transplant (OTHER).
Who is sponsoring clinical trial NCT05595837?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.